Whipple’s Disease Pathogen Found in International Diarrhea Patients
|
By LabMedica International staff writers Posted on 11 Mar 2021 |

Image: Micrograph of Whipple’s disease. This duodenal biopsy shows the characteristic feature of Whipple’s disease; foamy macrophages are present in the lamina propria cells (Photo courtesy of Nephron).
Tropheryma whipplei is the causative agent of Whipple’s disease. The organism has also been detected in the feces of healthy or asymptomatic persons and in the feces of patients with diarrhea. Symptoms tend to develop slowly over many years in most people with this disease.
Whipple’s disease is a rare bacterial infection that most often affects the joints and digestive system. Whipple’s disease interferes with normal digestion by impairing the breakdown of foods, and hampering the body's ability to absorb nutrients, such as fats and carbohydrates. Whipple’s disease can also infect other organs, including the brain, heart and eyes.
An international team of scientists led by DRK Krankenhaus (Neuwied, Germany) investigate the role of enteric T. whipplei, and examined fecal specimens of patients with diarrhea using conventional methods and PCR to detect enteric pathogens and T. whipplei. The aim was to collect epidemiologic evidence regarding a causative role of T. whipplei in diarrhea. They investigated a total of 590 fecal samples. In South Africa, 97 of 100 targeted samples were usable. In Singapore, 193 of 200 targeted specimens contained sufficient material; of these, 19 were originally submitted for bacterial culture, 77 for rotavirus antigen testing, and 97 for both. In Germany, they tested samples from 300 patients. In South Africa and Singapore, patients were mainly children, both outpatients and inpatients.
The scientists used the LightCycler 480 instruments (Roche Molecular Diagnostics, Pleasanton, CA, USA), with determination of crossing point (Cp) values in positive samples. Multiplex PCR testing for other pathogens was performed using LightMix Modular Gastroenteritis Panel kits (TIB Molbiol, Berlin, Germany), as reported for Escherichia coli.
The investigators reproved that overall, 56 patients had positive test results for T. whipplei in the feces: 17 (17.5%) in South Africa, 29 (15%) in Singapore, and 10 (3.3%) in Germany. In South Africa, T. whipplei was the most common fecal organism, followed by Shigella, rotavirus, and adenovirus. In Singapore, rotavirus was the most frequently detected organism, followed by norovirus, T. whipplei, and Salmonella. In Germany, Clostridioides difficile was the most frequently detected organism, followed by T. whipplei and Blastocystis hominis; viruses were not sought in Germany. The frequency of C. difficile likely reflects the high proportion of elderly inpatients.
Fecal specimens testing positive for T. whipplei averaged 0.91 other pathogens per specimen, in contrast to only 0.46 per specimen in those testing negative for T. whipplei. Similarly, of the fecal specimens testing positive for T. whipplei, 69.6% contained other pathogens, in contrast to only 34.5% of the specimens testing negative for T. whipplei. Specimens containing T. whipplei contained other pathogens about twice as frequently as specimens without T. whipplei. In Singapore, one specimen contained four pathogens: T. whipplei, Blastocystis, astrovirus, and Dientamoeba.
The authors concluded that using diagnostic specimens from microbiology laboratories on three continents, they were able to confirm that T. whipplei can be found frequently in the feces of patients with diarrhea. Across the three locations, the numbers of traditional enteropathogens were significantly increased in specimens also containing T. whipplei, and they found an association between the presence of T. whipplei and Campylobacter. The findings support the hypothesis that enteric T. whipplei may not be causative for diarrhea. but may possibly be a result of different sanitary and climatic conditions.
Related Links:
DRK Krankenhaus
Roche Molecular Diagnostics
TIB Molbiol
Whipple’s disease is a rare bacterial infection that most often affects the joints and digestive system. Whipple’s disease interferes with normal digestion by impairing the breakdown of foods, and hampering the body's ability to absorb nutrients, such as fats and carbohydrates. Whipple’s disease can also infect other organs, including the brain, heart and eyes.
An international team of scientists led by DRK Krankenhaus (Neuwied, Germany) investigate the role of enteric T. whipplei, and examined fecal specimens of patients with diarrhea using conventional methods and PCR to detect enteric pathogens and T. whipplei. The aim was to collect epidemiologic evidence regarding a causative role of T. whipplei in diarrhea. They investigated a total of 590 fecal samples. In South Africa, 97 of 100 targeted samples were usable. In Singapore, 193 of 200 targeted specimens contained sufficient material; of these, 19 were originally submitted for bacterial culture, 77 for rotavirus antigen testing, and 97 for both. In Germany, they tested samples from 300 patients. In South Africa and Singapore, patients were mainly children, both outpatients and inpatients.
The scientists used the LightCycler 480 instruments (Roche Molecular Diagnostics, Pleasanton, CA, USA), with determination of crossing point (Cp) values in positive samples. Multiplex PCR testing for other pathogens was performed using LightMix Modular Gastroenteritis Panel kits (TIB Molbiol, Berlin, Germany), as reported for Escherichia coli.
The investigators reproved that overall, 56 patients had positive test results for T. whipplei in the feces: 17 (17.5%) in South Africa, 29 (15%) in Singapore, and 10 (3.3%) in Germany. In South Africa, T. whipplei was the most common fecal organism, followed by Shigella, rotavirus, and adenovirus. In Singapore, rotavirus was the most frequently detected organism, followed by norovirus, T. whipplei, and Salmonella. In Germany, Clostridioides difficile was the most frequently detected organism, followed by T. whipplei and Blastocystis hominis; viruses were not sought in Germany. The frequency of C. difficile likely reflects the high proportion of elderly inpatients.
Fecal specimens testing positive for T. whipplei averaged 0.91 other pathogens per specimen, in contrast to only 0.46 per specimen in those testing negative for T. whipplei. Similarly, of the fecal specimens testing positive for T. whipplei, 69.6% contained other pathogens, in contrast to only 34.5% of the specimens testing negative for T. whipplei. Specimens containing T. whipplei contained other pathogens about twice as frequently as specimens without T. whipplei. In Singapore, one specimen contained four pathogens: T. whipplei, Blastocystis, astrovirus, and Dientamoeba.
The authors concluded that using diagnostic specimens from microbiology laboratories on three continents, they were able to confirm that T. whipplei can be found frequently in the feces of patients with diarrhea. Across the three locations, the numbers of traditional enteropathogens were significantly increased in specimens also containing T. whipplei, and they found an association between the presence of T. whipplei and Campylobacter. The findings support the hypothesis that enteric T. whipplei may not be causative for diarrhea. but may possibly be a result of different sanitary and climatic conditions.
Related Links:
DRK Krankenhaus
Roche Molecular Diagnostics
TIB Molbiol
Latest Microbiology News
- High-Throughput Automated Platform to Advance Latent Tuberculosis Testing
- Expanded Diagnostics and Therapies Target Rising Gonorrhea Resistance
- New Rapid Ebola Antigen Test Detects Infection at Point of Care
- Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation
- Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections
- Bacterial Growth Assay Predicts COVID-19 Severity From Plasma
- Gut Microbiome Analysis Identifies Frailty-Related Signatures in Older Adults
- CE-Marked Blood Assay Automates Tuberculosis Infection Testing
- Genomic Surveillance Algorithm Improves Early Detection of Emerging Variants
- Rapid Gastrointestinal PCR Panels Deliver One-Hour Results
- H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention
- Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
- Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella
- Stronger Laboratory Services Support Timely Melioidosis Diagnosis Amid Global Spread
- Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori
- Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE
Channels
Clinical Chemistry
view channel
Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers
Venous blood draws can be challenging in patients with difficult veins, needle phobia, or limited blood volume, and they can slow collection in busy services. Core laboratories also face pressure to expand... Read more
Preoperative Blood Test Predicts Colorectal Cancer Recurrence and Metastasis
Cancer cells require large amounts of nutrients to grow and proliferate, and amino acids support key processes including protein formation, energy production, and DNA synthesis. Colorectal cancer is marked... Read moreMolecular Diagnostics
view channel
Genomic Fingerprints Reveal Early Chemotherapy Resistance in Childhood Cancer
Chemotherapy remains central to treating childhood cancers, yet its toxic effects can injure healthy tissues, and some tumors later relapse or spread. Clinicians have lacked early molecular markers that... Read more
Blood Gene Expression Fluctuates More Than Expected Over Time
Blood-based gene expression is widely used to explore disease biology, but temporal variability can complicate interpretation of single time-point measurements. Seasonal shifts, time of day, and subclinical... Read more
Genomic Test Helps Early Breast Cancer Patients Avoid Chemotherapy
Adjuvant chemotherapy decisions in early breast cancer can expose many patients to toxicities without clear benefit when clinical factors alone do not precisely predict recurrence risk. Clinicians therefore... Read more
Residual Disease Test Predicts Merkel Cell Carcinoma Recurrence Earlier Than Antibody Assay
Merkel cell carcinoma is a rare, aggressive skin cancer with a substantial risk of relapse, occurring in about 40% of patients. Surveillance remains challenging because widely used serologic monitoring... Read moreHematology
view channel
Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma
imal residual disease (MRD) monitoring is pivotal in multiple myeloma, where persistent malignant plasma cells drive relapse risk and help guide therapy decisions. In the United States, approximately 202,000... Read more
New Marker Helps Detect Aggressive Multiple Myeloma Earlier
Multiple myeloma is an incurable malignancy of plasma cells and the second most common blood cancer worldwide, with more than 188,000 new cases each year. Although therapies have advanced, most patients... Read moreImmunology
view channel
Study Reveals Immune Mechanism Driving Severe COVID-19 Progression
Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more
Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis
Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis
Sjögren’s disease is a common autoimmune condition that can be difficult to recognize early, leading to delayed diagnosis and persistent symptom burden. It affects around half a million people in the UK... Read more
New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
Eurofins Viracor has introduced three plasma-based assays—CXCL9 (Test Code 33607), CXCL10 (Test Code 33609), and interleukin-18 (IL-18) (Test Code 33611)—expanding its immunology testing menu for transplant... Read morePathology
view channel
PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers
Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read more
AI Digital Pathology Platform Standardizes IHC Scoring in Breast Cancer
Breast cancer diagnostic workflows increasingly depend on accurate quantification of immunohistochemical biomarkers to guide therapy selection, yet manual scoring can be variable and time-consuming.... Read moreTechnology
view channel
Training Device Improves Accuracy of Pooled Molecular Diagnostics
High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read moreIndustry
view channel
Collaboration Advances Sputum-Based Diagnostics for Asthma and COPD
Asthma and chronic obstructive pulmonary disease are highly prevalent inflammatory airway conditions, affecting more than 40 million Americans and more than 650 million people worldwide.... Read more




 Assay.jpg)



